News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Valle Franco
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 4,273 shares
@ $3.7825, valued at
$16.2k
|
|
| 01/10/2023 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 126,300 options to buy
@ $7.05, valued at
$890.4k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 3,307 shares
@ $4.6665, valued at
$15.4k
|
|
| 01/18/2022 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 10,000 shares
@ $8.6767, valued at
$86.8k
|
|
| 12/07/2021 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 144,770 options to buy
@ $9.8, valued at
$1.4M
|
|
| 08/05/2021 |
4
| Valle Franco (CFO) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 165,000 options to buy
@ $13.45, valued at
$2.2M
|
|
| 08/05/2021 |
3
| Valle Franco (CFO) has filed a Form 3 on Biomea Fusion, Inc. |
| 01/28/2021 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 24,350 options to buy
@ $7.24, valued at
$176.3k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 1,623 shares
@ $74.9287, valued at
$121.6k
Exercised 1,623 options to buy
@ $7.24, valued at
$11.8k
|
|
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
|
|
| 04/22/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $49.79, valued at
$99.6k
Exercised 2,000 options to buy
@ $7.24, valued at
$14.5k
|
|
| 03/30/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $47.87, valued at
$143.6k
Sold 2,000 shares
@ $48.85, valued at
$97.7k
Exercised 5,000 options to buy
@ $7.24, valued at
$36.2k
|
|
| 03/04/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $51.96, valued at
$103.9k
Sold 1,000 shares
@ $53.06, valued at
$53.1k
Exercised 3,000 options to buy
@ $7.24, valued at
$21.7k
|
|
| 01/09/2020 |
3
| Valle Franco (Senior Vice President, Finance) has filed a Form 3 on Eidos Therapeutics, Inc. |
| 04/03/2017 |
3
| Valle Franco (Principal Accounting Officer) has filed a Form 3 on Lion Biotechnologies, Inc. |
|
|